CD274 and psoriasis: Current studies have shown that indirubin has a dose-dependent therapeutic effect on alleviating psoriasis-like skin lesions in mice (21), among which CD274 is a regulatory factor of indirubin-mediated effect on psoriasis-like skin lesions in mice (14).